Simpler Grants.gov #PAR-25-362

NIH Grant for Early Immune System Development Research (R01 Clinical Trial Optional)

This opportunity is a research grant solicitation from the National Institutes of Health (NIH) focused on early immune system development. - Government Buyer: - National Institutes of Health (NIH) - Scope of Research: - Studies on early immune system development and ontogeny - Focus on mechanisms in utero, early post-natal period, and early childhood - Includes research on neonates, infants, children, and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART) - Emphasis on immune cell mechanisms at the maternal-fetal interface, T and B cell development and maturation, and both local and systemic immune responses - Funding Details: - Grant funding instrument (not a contract for products or services) - Minimum award amount of $400,000 - No cost sharing or matching required - Eligibility: - Open to educational institutions, businesses, nonprofits, government entities, and other organizations - Notable Requirements: - No specific OEMs, vendors, or products are referenced, as this is a research grant opportunity - Clinical trials are optional under this funding opportunity

Description

This Notice of Funding Opportunity (NOFO) aims to elucidate mechanisms of early immune development in utero, early post-natal period, and early childhood in neonates, infants, and children with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART). The initiative focuses on understanding immune cells at the maternal-fetal interface, T and B cell development and maturation, local immune responses, and systemic immunity. The funding instrument is a grant with no cost sharing or matching requirement. Eligible applicants include a wide range of educational institutions, businesses, nonprofits, governments, and other organizations.

View original listing